Georgeson Inc. Is acting as information agent for Bristol-Myers Squibb. Morgan Stanley & Co. Included is serving as monetary advisor to Bristol-Myers Squibb in connection with the transactions and will be the dealer-manager for the tender give. Kirkland & Ellis LLP can be acting as lawyer to Bristol-Myers Squibb. Goldman, Sachs & Co. Is usually serving as financial advisors to ZymoGenetics regarding the the transactions and ZymoGenetics is normally represented by Latham & Watkins LLP.. Bristol-Myers Squibb Starts Tender Offer to Acquire ZymoGenetics, Inc. Bristol-Myers Squibb Firm is commencing today, through its owned subsidiary Zeus Acquisition Company wholly, a cash tender present to purchase all outstanding shares of common share of ZymoGenetics, Inc. . Bristol-Myers Squibb announced on Tuesday, 7 September, 2010 its intent to acquire ZymoGenetics.Ethosuximide and trimethadione did, however, delay age-related declines in neuro-muscular activity significantly. Treated worms continued to show the youthful traits of fast body motion and fast pumping of mouthparts through the latter stage of their prolonged lives. Further tests demonstrated that the anticonvulsants stimulated transmission of signals in nerves that control body motion. Related StoriesCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyStudy links antibiotic use during childhood to pounds gainDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixScientists had found genetic mutations in C previously.